Selective requirement for CD40-CD154 in drug-induced type 1 versus type 2 responses to trinitrophenyl-ovalbumin

Journal of Immunology

Volumn 168, Issue 8, 2002, Pages 3747-3754

  Nierkens, Stefan ^a   Van Helden, Pauline ^a   Bol, Marianne ^a   Bleumink, Rob ^a   Van Kooten, Peter ^a   Ramdien Murli, Seema ^a   Boon, Louis ^a   Pieters, Raymond ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD11 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 4; OVALBUMIN; PENICILLAMINE; PHENYTOIN; STREPTOZOCIN; TRINITROPHENYL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CELL INTERACTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; FEMALE; IMMUNE RESPONSE; LYMPH NODE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0037090250     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.8.3747     Document Type: Article

References (49)

1. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis
2. Ab to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease
3. CD40-CD40 ligand interaction in autoimmune disease
4. Anti-CD40 ligand Ab treatment of SNF1 mice with established nephritis: Preservation of kidney function
5. Anti-CD40 ligand Ab treatment prevents the development of lupus-like nephritis in a subset of New Zealand Black × New Zealand White mice: Response correlates with the absence of an anti-Ab response
6. Prevention of collagen-induced arthritis with an Ab to gp39, the ligand for CD40
7. CD40 ligand-CD40 interactions, are necessary for the initiation of insulitis and diabetes in non-obese diabetic mice
8. Chronic murine colitis is dependent on the CD154/CD40 pathway and can be attenuated by anti-CD154 administration
9. + T cells requires CD40-CD40 ligand interactions for a sustained increase in mucosal IL-12
10. Interleukin-12 production by dendritic cells: The role of CD40-CD40L interactions in Th1 T-cell responses
11. Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) Ab in an animal model of multiple sclerosis
12. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis
13. CD40-CD40 ligand
14. The CD40 antigen and its ligand
15. The role of CD40 in the regulation of humoral and cell-mediated immunity
16. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an Ab to the ligand for CD40, gp39
17. CD40 ligand-deficient mice generate a normal primary cytotoxic T-lymphocyte response but a defective humoral response to a viral infection
18. The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo
19. The relative contribution of the CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells
20. The roles of CD28 and CD40 ligand in T cell activation and tolerance
21. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper I cells through the inhibition of interleukin 12 secretion
22. CD40 ligand (CD154) enhances the Th1 and Ab responses to respiratory syncytial virus in the BALB/c mouse
23. Blockade of CD40-CD40 ligand pathway induces tolerance in murine contact hypersensitivity
24. Mucosally induced systemic T cell unresponsiveness to ovalbumin requires CD40 ligand-CD40 interactions
25. The use of reporter antigens in the popliteal lymph node assay to assess immunomodulation by chemicals
26. 2 and diphenylhydantoin stimulate IgG production to TNP-Ficoll and TNP-OVA, supporting and extending the graft-versus-host hypothesis for chemical induction of autoimmunity
27. 2
28. Quantification of natural Ab producing B cells in rats by an improved ELISPOT technique using the polyvinylidene difluoride membrane as the solid support
29. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins
30. The paradigm of Th1 and Th2 cytokines: Its relevance to autoimmunity and allergy
31. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation
32. Cutting edge: CD40 ligand is a limiting factor in the humoral response to T cell-dependent antigens
33. Induction of B cell costimulatory function by recombinant murine CD40 ligand
34. Rapid induction of a novel costimulatory activity on B cells by CD40 ligand
35. Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses
36. Ligation of CD28 in vivo induces CD40 ligand expression and promotes B cell survival
37. The regulation of T cell-dependent Ab formation in vitro by CD40 ligand and IL-2
38. Costimulatory regulation of T cell function
39. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy
40. + cytotoxic T cells
41. B7-2 (CD86) is essential for the development of IL-4-producing T cells
42. Regulation of T helper cell differentiation in vivo by soluble and membrane proteins provided by antigen-presenting cells
43. CD80 and CD86 are not equivalent in their ability to induce the tyrosine phosphorylation of CD28
44. Regulation of self-tolerance by CD80/CD86 interactions
45. + CTL response
46. CD40-CD40 ligand interactions in vivo regulate migration of antigen-bearing dendritic cells from the skin to draining lymph nodes
47. Activated T cells induce macrophages to produce NO and control Leishmania major in the absence of tumor necrosis factor receptor p55
48. Tolerance, danger, and the extended family
49. + T cell responses: The alternative approaches